Response to radiation.
Semin Radiat Oncol
; 14(4): 322-5, 2004 Oct.
Article
en En
| MEDLINE
| ID: mdl-15558507
ABSTRACT
Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tomografía Computarizada de Emisión
/
Carcinoma de Pulmón de Células no Pequeñas
/
Radiofármacos
/
Fluorodesoxiglucosa F18
/
Neoplasias Pulmonares
Límite:
Humans
Idioma:
En
Revista:
Semin Radiat Oncol
Asunto de la revista:
NEOPLASIAS
/
RADIOLOGIA
Año:
2004
Tipo del documento:
Article
País de afiliación:
Estados Unidos